A single-center experience of haploidentical stem cell transplantation in hematological malignancies.

Ümit Yavuz Malkan,Hakan Göker,Haluk Demiroğlu,Fatma Tekin,Nadire Buket Akdemir,Elifcan Aladağ Karakulak,Nilgün Sayınalp,İbrahim Celalettin Haznedaroğlu,Osman İlhami Özcebe,Yahya Büyükaşık

Turkish journal of medical sciences（2023）

引用 0|浏览2

暂无评分

摘要

In our center, we prefer to use high dose posttransplantation cyclophosphamide after haploidentical hematopoietic stem cell transplantation for graft-versus-host disease prophylaxis. With this approach, our center's overall survival and disease-free survival rates are comparable and compatible with the literature findings.

查看译文

关键词

Graft-versus-host disease,Haploidentical hematopoietic stem cell transplantation,conditioning regimens

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要